´ëÇÑ°£ÇÐȸ-´ëÇÑÃé´ãµµÇÐȸ Joint Symposium : 2023-01-28±³À°ÀÏÀÚ : 2023-01-28
±³À°Àå¼Ò : À¯ÇѾçÇà 4Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
´ëÇÑ°£ÇÐȸ-´ëÇÑÃé´ãµµÇÐȸ Joint SymposiumÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ :
kasl@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í ÇöÀåµî·Ïºñ 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 13:30~13:50 In depth understanding of cholestasis ±è°æ¾Æ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 13:50~14:10 Recent updates of IgG4-related sclerosing cholangitis ¹®¼ºÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 14:10~14:30 Updates in medical therapy for PSC and PBC °û±Ý¿¬(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 14:30~14:50 Endoscopic evaluation for indeterminate biliary stricture ÀÌÀ±³ª(¼øõÇâÀÇ´ë)
Åä·Ð 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 14:50~15:00 Q&A ()
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 15:20~15:40 Treatment for HCC with bile duct invasion: KASL¡¯s view ±è¹ü°æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 15:40~16:00 Treatment for HCC with bile duct invasion: KPBA¡¯s view ÀÌ»óÇù(¼¿ïÀÇ´ë)
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 16:00~16:20 Treatment for combined hepatocellular cholangiocarcinoma: KASL¡¯s view ½ÉÁÖÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 16:20~16:40 Treatment for combined hepatocellular cholangiocarcinoma: KPBA¡¯s view ¹ÚÁÖ°æ(¼º±Õ°üÀÇ´ë)
Åä·Ð 01-28 À¯ÇѾçÇà 4Ãþ ´ë°´ç 16:40~16:50 Q&A ()